The binding and catabolism of low density lipoprotein (LDL) were studied in cultured skin fibroblasts and/or Epstein-Barr virus-transformed lymphoblastoid cells from 20 familial hypercholesterolemic (FH) homozygotes of 14 Afrikaner kindreds. Cells from available heterozygotes were also analyzed. Good resolution between the normal, heterozygote, and homozygote groups was obtained on the basis of these assays using either cell type. Results obtained with fibroblasts allowed the classification of 13 of these kindreds as being typically receptor-defective, and one kindred with two homozygotes as being receptor-negative. Fibroblasts from homozygotes of the receptor-defective class expressed LDL receptor activities which varied between 3% and 25% of normal. Where two homozygotes from the same family were available for assays (six families), both yielded similar activities. In contrast to fibroblasts, all the lymphoblastoid cells derived from FH homozygotes yielded LDL receptor activities equal to or less than 10% of normal; in a number of cases no significant 
The binding and catabolism of low density lipoprotein (LDL) were studied in cultured skin fibroblasts and/or Epstein-Barr virus-transformed lymphoblastoid cells from 20 familial hypercholesterolemic (FH) homozygotes of 14 Afrikaner kindreds. Cells from available heterozygotes were also analyzed. Good resolution between the normal, heterozygote, and homozygote groups was obtained on the basis of these assays using either cell type. Results obtained with fibroblasts allowed the classification of 13 of these kindreds as being typically receptor-defective, and one kindred with two homozygotes as being receptor-negative. Fibroblasts from homozygotes of the receptor-defective class expressed LDL receptor activities which varied between 3% and 25% of normal. Where two homozygotes from the same family were available for assays (six families), both yielded similar activities. In contrast to fibroblasts, all the lymphoblastoid cells derived from FH homozygotes yielded LDL receptor activities equal to or less than 10% of normal; in a number of cases no significant F amilial hypercholesterolemia (FH) is transmitted as an autosomal dominant trait and is clinically characterized by elevated plasma levels of low density lipoprotein (LDL) cholesterol, xanthomas, atheromas, and coronary heart disease. 1 It is well established that defects giving rise to this disease reside in abnormalities or the absence of cell surface receptors for LDL. On the basis of LDL-binding studies in cultured cells, three types of defects were defined by Goldstein and Brown: 23 receptor-negative (no functional receptors); receptor-defective (markedly decreased receptor activity); and receptor internalization-defective (no internalization of receptors). The existence of multiple alleles in the former two classes was indicated from immunological studies using anti-LDL receptor antibodies." More recently, seven different mutant alleles for the LDL receptor have been identified, 5 ' 6 some of which are associated with defective processing of the receptor precursor molecule.
In 1982, we reported on the LDL receptor levels in fibroblasts from five South African FH homozygotes who received treatment at the Red Cross War Memorial Children's Hospital in Cape Town. 7 On the basis of this study, two of the patients were classified as homozygous for a receptor-defective abnormality with receptor activity of approximately 10% of normal. Receptor activities in fibroblasts from the other three patients were unexpectedly high (more than 25% of normal). These results indicated a possible genetic heterogeneity underlying the clinical picture associated with FH in one area of South Africa.
In another geographical region, an unusually large number of homozygous FH patients have been diagnosed in one clinic in Johannesburg (Transvaal Province). Some details on these patients were reported. 8 " 10 Each of the FH kindreds was predominantly Afrikaner, a population group descending from Dutch settlers who arrived in South Africa during the second half of the 17th century. Today their descendents number approximately 2.6 million, and because of geographical, religious, and cultural reasons they constitute a relatively homogeneous population genetically. The frequencies of FH homozygotes and heterozygotes in Transvaal Afrikaners were conservatively calculated at about 1 in 30,000 and 1 in 100, respectively. The prevalence of FH in Afrikaners is therefore considerably greater than in European and American populations, and a founder gene effect in the Afrikaner population has been proposed. 9 ' 10 In this paper we report on the LDL receptor levels in cultured skin fibroblasts and, in some cases, Epstein-Barr virus (EBV)-transformed lymphoblastoid cells from 20 of these homozygotes and the available family members from 14 kindreds.
Methods

Patients
Members of 14 FH kindreds, including 20 homozygous FH patients, were investigated in this study. The clinical characteristics and biochemical features (blood lipid concentrations) of 15 of the homozygous FH patients have been described previously. 9 Their blood lipid profiles and clinical data are summarized in Table 1 . The homozygous state of FH was diagnosed on the basis of the following criteria: 1) the presence of plasma cholesterol concentrations greater than 14.3 mmol/liter ( Figure 1) ; 2) the appearance of xanthomas in the first decade of life; and 3) the presence in both parents of hypercholesterolemia or clinical signs indicative of the heterozygous state. All 20 patients diagnosed as homozygous for FH met all three criteria. All had orange or yellow planar xanthomas in the skin over the limbs or buttocks, which, according to Fredrickson et al., 1 are specific for homozygotes and do not occur in heterozygotes. All parents showed the required degree of hypercholesterolemia (greater than 7 mmol/liter). In some kindreds, either one or both parents were not investigated for LDL receptor activity and are not described in Table 1 . However, these subjects all had total serum cholesterol levels greater than 8.8 mmol/liter and were diagnosed clinically as heterozygous for FH. None of the unions of natural parents was consanguineous, and the pedigrees (data on file with the National Auxiliary Publications Service) of all kindreds were consistent with a Mendelian inheritance pattern for an autosomal dominant abnormal- tion. All homozygous patients appeared to be of Afrikaner origin. Three homozygous FH individuals (7a, 7b, 13a) were natural parents of heterozygous FH children.
Lipid and Llpoproteln Assays
The serum lipids measured were total cholesterol and triglyceride, LDL cholesterol, and high density lipoprotein (HDL) cholesterol from fasting subjects. The assays were performed as previously described. 9 Each value (Table 1) represents the mean of at least three determinations carried out before treatment with drugs or surgery.
Cell Studies
Fibroblasts
Skin fibroblasts were established in culture from skin biopsies obtained, with informed consent, from the ventral surface of forearms. All procedures had the appropriate institutional approval. Patient treatment at the time of biopsy is given in Table 1 . Cultures were grown and assayed for 125 I-LDL binding, intracellular content, and degradation at 37 C C as well as for acyl-CoA cholesterol acyltransferase (ACAT) induction by LDL, using methods established by Goldstein et al. 11 -12 and carried out exactly as previously described. 7 To control for day-to-day variations, cells were always analyzed together with two normal control cell lines in the same experiment. This permitted the values of assay determinations in 
Coronary heart disease as evidenced by angina pectoris, myocardial infarction, or electrocardiographic changes. tTreatment at time of skin biopsy or blood collection. PCS = portacaval shunt; P = probucol; Q = questran; IC = index case; CHD = coronary heart disease; XMTA = xanthoma; Trig = triglyceride. unknown cell strains to be expressed as percentages of normal activity.
The 125 I-LDL and 125 l-lgG-C7 binding experiments at 4°C were performed according to the methods of Beisiegel, et al. 4 The methods for the isolation of human LDL (density = 1.019-1.063 g/ml), lipoprotein-deficient serum (LPDS) (density > 1.25 g/ml), and the iodination of LDL with 125 l-iodine were as described previously. 13 
Lymphoblastoid Cells
Medium containing EBV was prepared from semiconfluent cultures of the EBV-producing marmoset cell line B95/8.
14 Fresh Ham's F10 medium containing 15% fetal calf serum (FCS) (State Vaccine Institute, Cape Town) was added to the cells and removed 4 days later. Any B95/8 cells in this medium were removed by centrifugation followed by passage through a 0.45 /u.m membrane filter (Millipore, Bedford, Massachusetts). The medium was mixed with an equal volume of Ham's F10 medium containing 15% FCS. This mixture constituted the transformation medium and was effective for at least 3 months when stored at 4°C.
Lymphocytes were prepared from 10 to 20 ml of blood using either heparin or EDTA as the anticlotting agent. The blood was kept on ice for up to 24 hours before use. Aliquots of blood (10 ml) were layered above 5 ml Histopaque solution (Sigma Chemical Company, St. Louis, Missouri) and centrifuged at 1500 g for 20 minutes. The white cell band was removed and washed once with 10 ml Ham's F10 medium. The washed cell pellet was resuspended in 3 ml transformation medium, transferred to a 25 cm 2 tissue culture flask, and incubated at 37°C in a CO 2 incubator. Small volumes (0.5 to 1 ml) of medium were added, generally on alternate days, until rapid multiplication of transformed lymphoblasts allowed passage into new flasks. This generally took from between 1 to 3 weeks. Cells were routinely kept in suspension culture at densities between 0.1 x 10 6 and 1.0 x 10 6 cells per ml; medium (Eagle's MEM) containing 10% tryptose phosphate broth, 10% heatinactivated FCS, 60 /ug/ml penicillin G, and 100 fj.g/ ml streptomycin sulfate was changed every third day. Cells in these studies were assayed between 5 and 16 weeks in culture. No significant age-related changes in receptor activity have been detected in the case of control cell lines maintained in culture for periods of up to 24 weeks.
To assay cellular 125 I-LDL binding and metabolism, we upregulated cells (1 x 10 6 cells/ml for 48 hours in LPDS medium (Eagle's MEM containing LPDS at 5 mg protein/ml). The LPDS-containing medium was changed after 24 hours. This procedure resulted in maximal LDL receptor activity. The cells were then resuspended in fresh medium containing LPDS, and 125 I-LDL and unlabeled LDL were added at the required concentrations. Cells were dispensed in 35-mm culture dishes (1 ml containing approximately 2 x 10 6 cells/dish) with gentle aspiration, using a plastic Pasteur pipette to dissociate any aggregated cell clumps, and were then incubated at 37°C for 4 hours. Following incubation, the cell suspension was transferred to 15 ml plastic centrifuge tubes, and the cells were pelleted by centrifugation (2000 g for 3 minutes at 4°C). The medium was saved to determine the noniodide trichloroacetic acid-soluble degradation products as described previously. 7 The cell pellet was carefully suspended in 2.5 ml phosphate-buffered saline (PBS) containing 0.2% albumin, by two aspirations with a disposable plastic Pasteur pipette (Style NO. 202, Saint Amand Manufacturing Company, San Fernando, California). Centrifugation was repeated, and the washing procedure was repeated twice using PBS. All washing procedures were carried out at 4°C. The final pellet was suspended as above in 1 ml of ice-cold heparin (Sigma Chemical Company, St. Louis, Missouri, Grade II) solution (4 mg/ml in PBS) and incubated on ice for 1 hour. Cells and heparin solution were separated by centrifugation (2000 g for 6 minutes at 4°C). The heparin-releasable radioactivity was taken as a measure of cell surface-bound 
Results
To characterize the type of LDL receptor defect present in each of the kindreds mentioned earlier, we examined two cell types in culture. Skin fibroblasts and EBV-transformed lymphoblastoid cells were analyzed for their ability to bind, internalize, and degrade 125 I-LDL ( Table 2 ). The control EBV-transformed lymphoblastoid cells, which were derived from cells of normocholesterolemic individuals, internalized and degraded LDL by a receptor-mediated process similar to the LDL-pathway found in skin fibroblasts; 2 this included LDL binding to surfacereceptors, internalization, and degradation. The LDL receptors were subject to up-regulation and downregulation, and the internalized LDL induced ACAT activity (to be reported in detail elsewhere). In terms of cellular protein, lymphoblastoid cells expressed about one-third of the receptor activity of cultured fibroblasts, which is in agreement with values pre-viously reported for other lymphoid cells. 15 " 17 The LDL receptor activity in these cells was a relatively stable phenotype, since no significant differences in 125 I-LDL binding and catabolism were found in normal control cells kept in culture for up to 24 weeks.
As reported previously by others, 3 considerable variation in the receptor activity of the same cell strain was found between different experiments. This is reflected in the relatively large standard deviations obtained in the three parameters analyzed in the cells from the normocholesterolemic controls (Table 2) . For this reason, cells were always assayed under standard conditions and compared in each experiment to the two cell lines that were used throughout this study.
In all 20 homozygous FH cell strains, the clinical diagnosis was confirmed by the LDL receptor analyses using either fibroblasts, or lymphoblastoid cells, or both. In all cases, the cell strains from homozygotes yielded less than 25% of normal receptor activity measured in terms of (Figure 2 ). LDL binding was the parameter which provided the greatest discrimination between the normal and heterozygous groups.
Of the cell strains from homozygous patients, 1U showed receptor activities that were consistent with a receptor-defective classification (2% to 25% of normal activity). In none of the 14 kindreds thus affected was there evidence for a mutation affecting receptor intemalization, as opposed to receptor binding. The "internalization index," defined as the ratio of the amount of LDL internalized and degraded to that bound and previously used to identify internalizationdefective mutations, 18 ' 19 was within the normal range for all the cell strains examined from these kindreds. One kindred, in which two siblings (3a, 3b) were analyzed, appears to carry a receptor-negative type of mutation characterized by an absence of detectable functional receptors.
The ability of LDL to stimulate the incorporation of 14 C-oleate into cholesteryl oleate, as an index of cellular ACAT induction, was also measured to substantiate the receptor-negative status of these cells.
This method reputedly provides the most sensitive means of distinguishing between receptor-negative and receptor-defective homozygous cells; LDL causes a significant stimulation of ACAT in receptordefective cells, whereas this activity is undetectable in receptor-negative cells. 11 To control for variations in the esterification capacity of different cells and between different experiments, the ACAT activities induced by LDL were compared with those induced by 25-hydroxy-cholesterol; the latter effect does not depend on the receptor number. Fibroblasts from normocholesterolemic controls showed ratios within the reported normal range, while cells from the homozygous receptor-defective cells expectedly gave low, but detectable, values ( Table 3 ). The two homozygous cell lines from Kindred 3 showed no detectable LDL-induced ACAT activity, confirming the homozygous receptor-negative classification of these patients.
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fMean and standard deviation of normal controls assayed over a 10-month period. £Mean and standard deviation of normal controls assayed over a 5-month period.
Fibroblasts were seeded in medium containing 10% fetal calf serum at a density of 10 5 cells/60 mm dish. Medium was changed on Day 3. After 5 days (Day 5), the medium was changed to medium containing LPDS (5 mg protein/ml) in the place of fetal calf serum. On Day 6, the medium was replaced with a fresh aliquot of the same medium. On Day 7, each cell layer received 2 ml of medium containing LPDS plus 10 g protein/ml 125 I-LDL (150-350 cpm/ng), either in the absence or presence of 300 /xg protein/ml unlabeled LDL. After incubation for 4 hours at 37°C, the medium was removed, and its content of nonlodide trichloroacetic acid-soluble radioactivity measured (see reference 7). The receptor bound and intracellular radioactive content of the cell-layers were measured after washing and release of surface-bound LDL using dextran sulfate (10 mg/ml), as described in Methods. High-affinity values, which represent the difference between the values obtained in the absence and presence of unlabeled LDL, are presented. All values are the average of incubations carried out at each LDL concentration. High-affinity values for lymphoblastoid cells were determined as described in Methods. 'Cholesterol ester formation induced in the presence of LDL (200 p g proteinlml) plus 5 p I ethanol was compared with that induced in the presence of 25-hydroxycholesterol (1 0 pglml medium) added to LPDS medium in 5 p l ethanol.
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tMean ? standard deviation of eight normocholesterolemic controls.
found in the levels of receptor activity in the different homozygous receptor-defective fibroblasts. However, in the six families where two homozygous siblings were analyzed, the two homozygotes in each case showed much closer values for receptor activities than randomly paired samples in the homozygote group (Figure 3) . In two of the parameters measured (LDL intracellular and degradation), there was no overlap between the ranges of values of the different sibling pairs. As pointed out earlier, the defect can be described as receptor-negative in one kindred (Kindred 3), and receptor-defective in the others. In the receptor-defective group, the results suggest that there may be at least two subgroups; one can be described as low receptor-defective (1% to 10% of normal) and the other as high receptor-defective (1 1% to 25% of normal) (Figure 4) . In contrast to fibroblasts, the lymphoblastoid cells from all the FH homozygotes displayed activities of 10% of normal or less. In some kindreds where detectable receptor activities were observed in the fibroblasts from homozygous subjects (receptor-defective), no detectable binding activities were observed in lymphoblastoid cells from the same patients (Kindreds 4,9,11,13), although significant degradation was shown in three of these lines (4b,9a,13a) . The rea- Table 2 . High affinity values for lZ51-LDL degradation are expressed as a percentage of normal activity. Table 1 . On Day 7 of cell growth, monolayers from a given cell strain were divided into two groups. One group of cells received 1.5 ml of ice-cold medium containing 10% LPDS and 14 nM 125 I-LDL in the absence or presence of 700 nM unlabeled LDL. The remaining cells received 1.5 ml of ice-cold medium containing 10% LPDS and 6.6 nM 125 MgG-C7 in the absence or presence of 1 ^M unlabeled lgG-C7. After incubation for 2 hours at 4°C, the amount of 125 I-LDL and 1 2 5 IlgG-C7 bound to the cells was determined. High-affinity binding was calculated by subtracting the values of 125 l-ligand binding in the presence of unlabeled ligand (nonspecific binding) from that in its absence (total binding). Each value represents the average of triplicate incubations carried out on each cell strain.
son for the relatively lower activity in FH lymphoblastoid cells as compared with fibroblasts is not known.
As an alternative approach to assessing the number of receptors on cultured fibroblasts, the binding to cells of a monoclonal antibody (lgG-C7) to the LDL receptor was investigated. The binding of 125 l-labeled lgG-C7 to cells at 4°C was measured in four cell lines from homozygous FH patients (Table 4) . As reported previously, 4 approximately equilmolar amounts of 125 l-lgG-C7 and 125 I-LDL bound to normal cells. In each of the cell strains from homozygous patients, both 125 l-lgG-C7 and 125 I-LDL binding were markedly reduced compared with normal cells. Therefore, no evidence was found for the presence in any of these cells of the type of mutation (identified previously 4 ) that is associated with a disproportionately high antibody binding relative to LDL binding.
Discussion
The unusually high frequency of familial hypercholesterolemia in South Africa 8 affords a unique opportunity to study familial hypercholesterolemia and LDL receptors in a large group of FH patients from a relatively homogeneous population group, the Afrikaners. As noted previously, 9 ' 10 the Afrikaners are descended from a few Dutch, German, and French founder families who settled in the Cape during the second half of the 17th century, and as a result of social isolation and religious beliefs, are a genetically homogeneous group. A "founder gene" effect was proposed to account for the very high prevalence of FH in this group. 10 This hypothesis was supported by the demonstration of a striking association between FH and affiliation with the Reformed Church, the smallest of the three main Afrikaans religious groups in South Africa. 20 The 14 index case families investigated in this study were all Afrikaans-speaking, and nine were affiliated with the Reformed Church (M. Torrington and J. L. Botha, unpublished observations).
The present receptor studies using cultured cells have indicated a predominance of a receptor-defective type of mutation in this group. Taking into account the three homozygous FH subjects previously characterized, 7 we find that 16 of the 17 Afrikaner FH kindreds investigated appear to carry a receptor-defective type of mutation. Two other South African FH homozygotes described by us 7 were not predominantly Afrikaner in background. Goldstein and Brown 21 noted an earlier onset of coronary heart disease and a higher frequency of coronary deaths in receptor-negative homozygotes as compared to receptor-defective homozygotes, and the clinical features of the homozygotes described in this study corroborate this. In 18 receptor-defective homozygotes, none under the age of 16 years showed signs of coronary heart disease (CHD), although the frequency of CHD in receptor-negative homozygotes of all age groups examined is approximately 60%. 21 It was noteworthy that even the younger (aged 10) of the two receptor-negative siblings identified suffered from CHD.
None of the cell strains analyzed showed any evidence for the rare internalization defect described previously, 18 ' 19 and only one kindred (Kindred 3) carried a receptor-negative type of mutation, since two homozygous siblings showed negligible receptor activity or ACAT inducibility. Heterogeneity has been seen in both the receptor-defective and receptornegative classes, 4 ' 5e and the term, homozygote, is used here as an operational description of severely affected individuals who have inherited two mutant alleles at the receptor locus, although they may, in fact, be genetic compounds of differing defective alleles. Tolleshaug et al. 6 have recently reported on receptor mutations in fibroblasts from 77 homozygous FH subjects, 38 of whom were characterized as receptor-negative. However, 15 showed immunoprecipitable protein on cell surfaces when analyzed using an anti-LDL receptor monoclonal antibody, and only 12 failed to produce any immunoprecipitable protein. Altogether, seven mutations affecting LDL receptor phenotype were identified, and the existence of at least seven mutant alleles at the LDL receptor locus was postulated.
The homozygous receptor-defective fibroblasts presented in this study exhibited between 3% and 25% of normal receptor activity. In these FH homozygotes, no correlations were found between receptor activity in fibroblasts and the degree of xanthamatosis or cardiovascular disease or the response to treatment. The basis for this variation in receptor activity in the receptor-defective homozygotes is not known. One possibility is the presence in this group of more than one mutant allele for the LDL receptor, but the genetic homogeneity of this population makes this unlikely. Interestingly, in families where two homozygous subjects were assayed, the two yielded extremely similar values in each case. This suggests that genetic factors other than the LDL receptor locus may influence the expression of receptor activity, if there is a single mutant allele in Afrikaners. As pointed out by others, 3 it is impossible to ascertain the true genetic makeup of subjects on the basis of LDL binding studies alone; for example, genetic compounds of different mutant alleles are encountered. Using receptor antibodies 56 and ligandblotting techniques 22 will enable us to further characterize the types and number of mutant alleles in the receptor-defective group described here. Preliminary studies (Goldstein JL and Brown MS, personal communication) have indicated that the mutation in cells from three homozygous subjects (1a, 3a, 6a) each appeared to involve the synthesis of a structurally abnormal precursor that is converted to the mature form at a slow rate. This mutation is similar to that found in the O family and the Watanabe rabbit. 23 These findings argue further for a common mutation among South African Afrikaner homozygotes.
Epstein-Barr virus infects human B lymphocytes and transforms them into permanent lymphoblastoid cell lines.
14 These virus-transformed lymphoblastoid cells provide a new and convenient system for measuring LDL receptor activity. The presence of functional LDL receptors on long-term phytohemagglutinin-activated lymphoid cell lines was detected by Kayden et al. 24 and Ho et al. 15 The latter workers also showed that cells from one homozygous FH patient were devoid of such receptors. Our studies, which analyzed a number of cell lines derived from unaffected subjects and FH patients, establish the validity of using virus-transformed lymphoblastoid cell lines to detect mutant LDL receptor alleles in human subjects and to quantify receptor-mediated LDL binding and metabolism. The advantages of this procedure include the ease and acceptibility of blood collection, the ease of sample transport, the relatively short period required to establish rapidly growing long-term cultures, and the simplicity of culturing large numbers of these cells in suspension.
Our results obtained using lymphoblastoid cells and fibroblasts, indicate the predominance of a receptor-defective type of abnormality and support the concept of a founder gene effect underlying familial hypercholesterolemia in the Afrikaner population.
